7Baggers
 Published on: 2025-10-03 01:17:50  newser.com Fri, 03 Oct 2025 06:17:50 GMT
 pliant stock plunges 61% amid study pause, downgrades  MSN Sun, 21 Sep 2025 13:35:44 GMT
 pliant pauses mid-stage trial for lung disease therapy  MSN Wed, 17 Sep 2025 22:39:43 GMT
 nuveen llc acquires new stake in pliant therapeutics, inc. $plrx  MarketBeat Thu, 11 Sep 2025 19:42:18 GMT
 nuveen llc invests $315,000 in pliant therapeutics, inc. $plrx  MarketBeat Thu, 11 Sep 2025 07:00:00 GMT
 Penny Stocks To Watch With Market Caps Under $700M  simplywall.st Mon, 08 Sep 2025 07:00:00 GMT
 published on: 2025-09-05 06:24:37  Newser Fri, 05 Sep 2025 11:24:37 GMT
 published on: 2025-09-02 05:09:14  Newser Tue, 02 Sep 2025 10:09:14 GMT
 published on: 2025-08-31 16:22:26  Newser Sun, 31 Aug 2025 21:22:26 GMT
 published on: 2025-08-30 22:09:36  Newser Sun, 31 Aug 2025 03:09:36 GMT
 published on: 2025-08-29 18:11:49  Newser Fri, 29 Aug 2025 23:11:49 GMT
 published on: 2025-08-29 15:47:58  Newser Fri, 29 Aug 2025 20:47:58 GMT
 published on: 2025-08-28 05:17:08  Newser Thu, 28 Aug 2025 10:17:08 GMT
 published on: 2025-08-27 23:53:44  Newser Thu, 28 Aug 2025 04:53:44 GMT

Pliant Therapeutics, Inc
(NASDAQ:PLRX) 

PLRX stock logo

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of av6 and ...

Founded: 2015
Full Time Employees: 70
CEO: Bernard Coulie  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends